Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 22.51%216.06M | 15.50%173.26M | 4.76%138.88M | 11.42%648.32M | -23.62%188.22M | 28.40%176.37M | 44.19%150M | 40.97%132.57M | 60.31%581.87M | 46.92%246.44M |
| Cost of revenue | 21.66%142.29M | 11.63%110.25M | -20.75%72.67M | 2.53%425.33M | -34.20%118.19M | 24.03%116.96M | 31.48%98.76M | 39.27%91.7M | 52.40%414.86M | 47.19%179.61M |
| Gross profit | 24.18%73.77M | 22.96%63.01M | 62.01%66.21M | 33.52%222.99M | 4.79%70.03M | 37.96%59.41M | 77.17%51.24M | 44.94%40.87M | 84.02%167.01M | 46.19%66.83M |
| Operating expense | 31.56%34.63M | 35.94%35.22M | 34.79%39.1M | 13.34%98.71M | -16.22%30.14M | 20.28%26.32M | 47.07%25.9M | 72.00%29.01M | 102.48%87.09M | 129.30%35.98M |
| Other operating expenses | 31.56%34.63M | 35.94%35.22M | 34.79%39.1M | 35.66%126.33M | -16.22%30.14M | 20.28%26.32M | 47.07%25.9M | 72.00%29.01M | 80.10%93.12M | 53.82%35.98M |
| Total other operating income | ---- | ---- | ---- | 358.02%27.62M | ---- | ---- | ---- | ---- | -30.65%6.03M | ---- |
| Operating profit | 18.30%39.14M | 9.68%27.79M | 128.58%27.11M | 55.50%124.28M | 29.30%39.89M | 56.23%33.09M | 124.04%25.34M | 4.65%11.86M | 67.39%79.92M | 2.76%30.85M |
| Net non-operating interest income (expenses) | 17.82%-13.81M | -140.39%-18.66M | -152.85%-17.64M | -105.07%-53.2M | -27.46%-16.92M | -148.67%-16.81M | -187.66%-7.76M | -117.46%-6.98M | -198.93%-25.94M | -246.76%-13.28M |
| Non-operating interest income | ---- | ---- | ---- | 89.73%1.75M | ---- | ---- | ---- | ---- | 8.59%924.34K | ---- |
| Non-operating interest expense | -17.82%13.81M | 140.39%18.66M | 152.85%17.64M | 104.54%54.96M | 27.46%16.92M | 148.67%16.81M | 187.66%7.76M | 117.46%6.98M | 181.93%26.87M | 183.70%13.28M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -2.02K | 0 | ||||||||
| Special income (charges) | -270.23%-1.32M | 114.47%776.88K | ||||||||
| Less:Write off | ---- | ---- | ---- | 270.23%1.32M | ---- | ---- | ---- | ---- | -114.47%-776.88K | ---- |
| Other non-operating income (expenses) | -44.27%647K | 502.93%1.24M | -70.93%289K | -30.42%4.2M | -64.86%1.84M | 177.75%1.16M | 1.99%205K | 428.72%994K | 6.03M | 5.22M |
| Income before tax | 48.96%25.98M | -41.68%10.37M | 66.01%9.76M | 27.39%69.75M | 8.81%24.8M | 17.54%17.44M | 101.78%17.78M | -29.30%5.88M | 62.48%54.75M | 9.45%22.79M |
| Income tax | 123.64%7.3M | -75.07%1.7M | -19.91%1.28M | 10.07%24.51M | 4.84%9.23M | -50.24%3.27M | 151.36%6.83M | -61.91%1.59M | 65.41%22.26M | -6.38%8.81M |
| Net income | 31.75%18.67M | -20.87%8.67M | 97.95%8.48M | 39.25%45.24M | 11.30%15.57M | 71.30%14.17M | 79.69%10.96M | 3.70%4.28M | 60.52%32.49M | 22.50%13.99M |
| Net income continuous operations | 31.75%18.67M | -20.87%8.67M | 97.95%8.48M | 39.25%45.24M | 11.30%15.57M | 71.30%14.17M | 79.69%10.96M | 3.70%4.28M | 60.52%32.49M | 22.50%13.99M |
| Net income discontinuous operations | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Noncontrolling interests | -86.98%360K | -50.15%166K | 527.76%1.43M | 755.84%4.88M | 444.89%1.89M | 1,028.57%2.77M | 200.91%333K | -204.55%-335K | -554.50%-743.96K | -11,636.99%-548K |
| Net income attributable to the company | 60.53%18.31M | -19.96%8.5M | 52.57%7.05M | 21.45%40.36M | -5.90%13.68M | 42.09%11.41M | 65.29%10.62M | 8.91%4.62M | 63.28%33.23M | 27.25%14.54M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 60.53%18.31M | -19.96%8.5M | 52.57%7.05M | 21.45%40.36M | -5.90%13.68M | 42.09%11.41M | 65.29%10.62M | 8.91%4.62M | 63.28%33.23M | 27.25%14.54M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 18.29%0.0207 | -31.43%0.0096 | 67.24%0.0097 | 14.51%0.0513 | 0.53%0.0189 | 56.25%0.0175 | 70.73%0.014 | 3.57%0.0058 | 62.91%0.0448 | 20.51%0.0188 |
| Diluted earnings per share | 18.29%0.0207 | -31.43%0.0096 | 67.24%0.0097 | 14.51%0.0513 | 0.53%0.0189 | 56.25%0.0175 | 70.73%0.014 | 3.57%0.0058 | 62.91%0.0448 | 20.51%0.0188 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.